Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

Notes Allotment Intimation

8 Sep 2021 14:17

RNS Number : 1559L
Axis Bank Limited
08 September 2021
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/274/2021-22

 

September 8, 2021

Dear Sir(s),

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Listing Regulations")

 

This is with reference to our letter no. AXIS/CO/CS/251/2021-22 dated August 30, 2021, wherein we had informed that the Bank has initiated the process of issuing of the debt instruments in the form of the Additional Tier 1 Notes in foreign currency, subject to market conditions. We also refer to our letter no. AXIS/CO/CS/262/2021-22 dated September 2, 2021, wherein we had informed that the Bank, acting through its GIFT City branch, has completed the pricing of its U.S. dollar denominated Basel III compliant Additional Tier 1 Notes (the "Notes").

 

We are pleased to inform that the Bank has raised USD 600,000,000 through the issue and allotment of USD denominated, unsecured, 4.10% Basel III compliant, Additional Tier 1 Notes (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act.

 

The Notes will be listed on Singapore Exchange Limited, International Securities Market, India International Exchange (IFSC) Limited and the NSE IFSC Limited (NSE International Exchange).

 

This is for information of all concerned, in compliance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

 

Thanking you,

 

Yours sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary

 

DISCLAIMER

 

The Offering Circular ("OC") for the GMTN programme has not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Registrar of Companies ("RoC"), the Securities and Exchange Board of India ("SEBI") or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules framed thereunder or any other applicable Indian laws.

 

The OC has not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the SEBI, the RoC, the Reserve Bank of India, or any stock exchange in India. This OC and the Additional Tier 1 Notes ("Notes") are not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

 

This information relates to an offering of the Notes to be offered and sold (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act. This information is not an offer of securities for sale in the United States. The Notes referred to herein have not been and will not be registered under the U.S. Securities Act or the laws of any state of the United States or elsewhere and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws of the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States or in any other jurisdiction. Nothing in this communication shall constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer or sale would be unlawful. No money, securities or other consideration is being solicited by this announcement or the information contained herein and, if sent in response to this announcement or the information contained herein, will not be accepted.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNPEFLFEFA
Date   Source Headline
25th Jul 202212:33 pmRNSOutcome of Board meeting
20th Jul 20226:17 pmRNSIntimation of Earnings Call
12th Jul 20225:22 pmRNSRe-appointment of Chairman of the Bank
6th Jul 20228:27 amRNSBoard Meeting Intimation
5th Jul 20229:21 amRNSNOTICE OF 28TH ANNUAL GENERAL MEETING
24th Jun 20224:39 pmRNSRe-appointment of Deputy Managing Director
20th Jun 20222:39 pmRNSMOODY’S INVESTORS SERVICE RATING ACTION
16th Jun 20227:00 amRNSCredit Rating
1st Jun 20226:01 pmRNSCredit Rating
12th May 202210:11 amRNSCredit Rating Action
29th Apr 20221:48 pmRNSOutcome of Board Meeting - April 29, 2022
28th Apr 20222:57 pmRNSDisclosure of Related Party Transactions
28th Apr 202212:51 pmRNSOutcome of Board Meeting held on April 28, 2022
25th Apr 20221:44 pmRNSEarnings call intimation
11th Apr 20223:54 pmRNSPostal Ballot Results
8th Apr 20225:12 pmRNSRATING ACTION BY CARE RATINGS LIMITED
8th Apr 20221:02 pmRNSINTIMATION FOR BOARD MEETING
7th Apr 20221:26 pmRNSRATING ACTION BY CRISIL RATINGS LIMITED
30th Mar 20221:04 pmRNSPurchase of Citibank’s India Consumer Business
29th Mar 202210:34 amRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
28th Mar 20222:23 pmRNSAmendments to Fair Disclosure Code
22nd Mar 20222:38 pmRNSGrant of Stock Options
7th Mar 20223:19 pmRNSResults of Postal Ballot
4th Feb 20227:00 amRNSNotice of postal ballot
24th Jan 202212:36 pmRNSFinancial Results for quarter - December 31, 2021
18th Jan 20222:23 pmRNSEarnings Call - Update on Financial Results
10th Jan 20221:00 pmRNSAppointment of Company Secretary
10th Jan 202212:58 pmRNSRe-appointment of Deputy Managing Director
29th Dec 20217:00 amRNSRE-DESIGNATION
22nd Dec 202111:28 amRNSAllotment of Securities
21st Dec 20217:00 amRNSReclassification of Promoter
20th Dec 20217:00 amRNSUpdates
20th Dec 20217:00 amRNSCessation of Director
16th Dec 202112:13 pmRNSBoard Meeting to consider Financial Results
15th Dec 20211:58 pmRNSRating Action By Crisil Ratings Limited
15th Dec 20211:46 pmRNSRating action by ICRA Limited
14th Dec 202112:57 pmRNSAppointment of Director
9th Dec 20211:16 pmRNSApproval of Grant of Stock Options
30th Nov 20211:04 pmRNSReclassification of Promoters
30th Nov 20217:00 amRNSFitch Ratings Action
27th Oct 20211:25 pmRNSRe-designation - Deputy Managing Director
26th Oct 20212:17 pmRNSRelated Party Disclosure
26th Oct 20211:54 pmRNSUnaudited Financial Results - 30.09.2021
21st Oct 20217:33 amRNSEarnings call - Financial Results of the Bank
14th Oct 20213:29 pmRNSRe-appointment of Managing Director & CEO
12th Oct 202112:52 pmRNSReclassification of Promoter
29th Sep 20211:46 pmRNSChange in Director(s)
15th Sep 202112:34 pmRNSReclassification of Promoter
8th Sep 20212:17 pmRNSNotes Allotment Intimation
7th Sep 20214:12 pmRNSRating Action by CARE Ratings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.